![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Escalon Medical Corp (QB) | USOTC:ESMC | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.16 | 0.1321 | 0.18 | 0.00 | 21:05:49 |
|
|
|
Pennsylvania
|
|
33-0272839
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
Large accelerated filer
|
|
o
|
|
Accelerated filer
|
|
o
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
o
|
|
|
Page
|
Part III
|
|
|
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
|
|
Item 14.
|
|
|
|
|
|
Signature
|
|
|
|
|
|
Item 10.
|
Directors and Executive Officers and Corporate Governance
|
Name
|
|
Age
|
|
Position
|
|
Richard J. DePiano
|
|
77
|
|
|
Chairman
|
Richard J. DePiano, Jr.
|
|
52
|
|
|
Chief Executive Officer, President and General Counsel and Director
|
Mark G. Wallace
|
|
49
|
|
|
Chief Operating Officer and Principal Financial & Accounting Officer
|
Lisa A. Napolitano
|
|
55
|
|
|
Director
|
C. Todd Trusk
|
|
51
|
|
|
Director
|
John P. Dogum
|
|
52
|
|
|
Director
|
David J. Jocavinni
|
|
42
|
|
|
Director
|
|
|
•
|
The Company is obligated to pay the executive $8,000 per month for life, with payments commencing the month after retirement. The payout was been $8,491 per month adjust for cost of living and continued in 2018.
|
Name and Principal Position (2)
|
|
Year
|
|
Salary
|
|
Bonus
|
|
Stock
Awards
|
|
Option
Awards (1)
|
|
Non-Equity
Incentive Plan
Compensation
|
|
Nonqualified
Deferred
Compensation
Earnings
|
|
All Other
Compensation (1)
|
|
Total
|
||||||||||||||||
Richard J. DePiano
Chairman
|
|
2018
|
|
$
|
26,000
|
|
|
|
|
|
|
$
|
—
|
|
|
|
|
|
|
$
|
111,981
|
|
|
$
|
137,981
|
|
||||||||
|
2017
|
|
$
|
26,000
|
|
|
|
|
|
|
$
|
—
|
|
|
|
|
|
|
$
|
111,981
|
|
|
$
|
137,981
|
|
|||||||||
2016
|
|
$
|
31,000
|
|
|
|
|
|
|
$
|
6,038
|
|
|
|
|
|
|
$
|
111,981
|
|
|
$
|
149,019
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Richard J. DePiano, Jr.
Chief Executive Officer, President and General Counsel
|
|
2018
|
|
$
|
182,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
12,222
|
|
|
$
|
194,222
|
|
2017
|
|
$
|
182,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
12,222
|
|
|
$
|
194,222
|
|
||
2016
|
|
$
|
182,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
18,690
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
12,222
|
|
|
$
|
212,912
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Mark Wallace
Chief Operating Officer and Principal Financial & Accounting Officer
|
|
2018
|
|
$
|
149,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
810
|
|
|
$
|
149,810
|
|
|
2017
|
|
$
|
149,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
810
|
|
|
$
|
149,810
|
|
|
2016
|
|
$
|
154,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
14,537
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
810
|
|
|
$
|
169,347
|
|
Option Awards
|
|||||||||||||||
Name
|
|
Number of
Securities
Underlying
Unexercised
Options
|
|
Number of
Securities
Underlying
Unexercised
Options
|
|
Equity
Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
|
|
Option
Exercise
Price
|
|
Option
Expiration
Date
|
|||||
|
|
Exercisable
|
|
Unexercisable
|
|
|
|
|
|
|
|||||
Richard J. DePiano
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
25,000
|
|
|
—
|
|
|
—
|
|
|
$
|
2.22
|
|
|
9/26/2018
|
|
|
20,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.51
|
|
|
11/16/2019
|
|
|
10,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.57
|
|
|
5/7/2024
|
|
|
10,000
|
|
|
—
|
|
|
—
|
|
|
$
|
0.79
|
|
|
5/7/2026
|
Richard J. DePiano, Jr.
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
20,000
|
|
|
—
|
|
|
—
|
|
|
$
|
2.22
|
|
|
9/26/2018
|
|
|
12,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.51
|
|
|
11/16/2019
|
|
|
45,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.57
|
|
|
5/7/2024
|
Mark Wallace
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
20,000
|
|
|
—
|
|
|
—
|
|
|
$
|
2.22
|
|
|
9/26/2018
|
|
|
10,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.51
|
|
|
11/16/2019
|
|
|
35,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.57
|
|
|
5/7/2024
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
Name
|
|
Amount of
Beneficial
Ownership
of
Outstanding
Shares (1)
|
|
Percent
of Class
|
|
Amount of
Beneficial
Ownership of
Shares
Underlying
Options
|
|
Amount of
Aggregate
Beneficial
Ownership
|
|
Aggregate
Percent of
Class
|
|
|||||||
Richard J. DePiano
|
|
4,440,627
|
|
(2
|
)
|
37.9
|
%
|
(2)
|
65,000
|
|
|
4,505,627
|
|
(2
|
)
|
38.2
|
%
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Richard J. DePiano, Jr.
|
|
—
|
|
|
—
|
%
|
|
77,000
|
|
|
77,000
|
|
|
*
|
|
|
||
Mark G. Wallace
|
|
—
|
|
|
—
|
%
|
|
65,000
|
|
|
65,000
|
|
|
*
|
|
|
||
Lisa A. Napolitano
|
|
—
|
|
|
—
|
%
|
|
56,000
|
|
|
56,000
|
|
|
*
|
|
|
||
C. Todd Trusk
|
|
—
|
|
|
—
|
%
|
|
7,000
|
|
|
7,000
|
|
|
*
|
|
|
||
John P. Dogum
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
|
|
*
|
|
|
||
David J. Jocavinni
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
|
|
*
|
|
|
||
All Directors and Executive Officers as a group (7 persons)
|
|
4,440,627
|
|
|
37.9
|
%
|
|
270,000
|
|
|
4,710,627
|
|
|
38.9
|
%
|
|
(*)
|
Less than on percent
|
Plan Category
|
|
Number of Shares to be
issued upon exercise of
outstanding stock options
(a)
|
|
Weighted-average exercise
price of outstanding stock
options
(b)
|
|
Number of securities remaining
available for future issuance
under equity compensation plans
(excluding securities reflected in
column a))
(c)
|
||||
Equity Compensation plans approved by shareholders
|
|
367,500
|
|
|
$
|
1.78
|
|
|
|
|
Equity Compensation plans not approved by shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
367,500
|
|
|
$
|
2.12
|
|
|
—
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
ITEM 14.
|
Principal Accounting Fees and Services
|
|
|
For the years ended June 30,
|
||||||
|
|
2018
|
|
|
2017
|
|
||
Audit Fees
|
|
$
|
133,000
|
|
|
$
|
130,000
|
|
Audit-Related Fees
|
|
$
|
—
|
|
|
$
|
—
|
|
Tax Fees
|
|
$
|
—
|
|
|
$
|
—
|
|
All Other Fees
|
|
$
|
—
|
|
|
$
|
—
|
|
Total Fees
|
|
$
|
133,000
|
|
|
$
|
130,000
|
|
|
|
|
Escalon Medical Corp.
(Registrant)
|
||
|
|
|
By:
|
|
/s/ Richard J. DePiano, Jr.
|
|
|
Richard J. DePiano, Jr.
|
|
|
Chief Executive Officer
|
1 Year Escalon Medical (QB) Chart |
1 Month Escalon Medical (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions